BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27793646)

  • 1. 6 HCV genotyping 9G test and its comparison with VERSANT HCV genotype 2.0 assay (LiPA) for the hepatitis C virus genotyping.
    Chantratita W; Song KS; GunHo C; Pongthanapisith V; Thongbaiphet N; Wongtabtim G; Pasomsub E; Angkanavin K; Nimse SB; Sonawane MD; Warkad SD; Kim T
    J Virol Methods; 2017 Jan; 239():1-8. PubMed ID: 27793646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples.
    Warkad SD; Nimse SB; Song KS; Chantratita W; Pongthanapisith V; Nawale LU; Kim T
    Virol J; 2018 Jul; 15(1):107. PubMed ID: 29996859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital.
    Goletti S; Zuyten S; Goeminne L; Verhofstede C; Rodriguez-Villalobos H; Bodeus M; StÀrkel P; Horsmans Y; Kabamba-Mukadi B
    BMC Infect Dis; 2019 Aug; 19(1):738. PubMed ID: 31438880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.
    Verbeeck J; Stanley MJ; Shieh J; Celis L; Huyck E; Wollants E; Morimoto J; Farrior A; Sablon E; Jankowski-Hennig M; Schaper C; Johnson P; Van Ranst M; Van Brussel M
    J Clin Microbiol; 2008 Jun; 46(6):1901-6. PubMed ID: 18400913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
    Comanor L; Elkin C; Leung K; Krajden M; Kronquist K; Nicolas K; Horansky E; deMedina M; Kittichai P; Sablon E; Ziermann R; Sherlock C
    J Clin Virol; 2003 Sep; 28(1):14-26. PubMed ID: 12927747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6 HCV Genotyping 9G test for HCV 1a, 1b, 2, 3, 4 and 6 (6a, 6f, 6i and 6n) with high accuracy.
    Chantratita W; Song KS; Nimse SB; Pongthanapisith V; Thongbaiphet N; Wongtabtim G; Pasomsub E; Angkanavin K; Sonawane MD; Warkad SD; Kim T
    J Virol Methods; 2017 Aug; 246():95-99. PubMed ID: 28456667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay.
    Manee N; Thongbaiphet N; Pasomsub E; Chantratita W
    J Virol Methods; 2017 Nov; 249():31-37. PubMed ID: 28851606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.
    Peiffer KH; Kuhnhenn L; Stelzl E; Dietz J; Susser S; Tal AO; Finkelmeier F; Zuckerman E; Cornberg M; Barak M; Piazzolla V; Mangia A; Zeuzem S; Kessler HH; Vermehren J; Sarrazin C
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31043467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping of hepatitis C virus-comparison of three assays.
    Haushofer AC; Berg J; Hauer R; Trubert-Exinger D; Stekel HG; Kessler HH
    J Clin Virol; 2003 Aug; 27(3):276-85. PubMed ID: 12878092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing.
    Yusrina F; Chua CW; Lee CK; Chiu L; Png TS; Khoo MJ; Yan G; Lee GH; Yan B; Lee HK
    J Virol Methods; 2018 May; 255():8-13. PubMed ID: 29428399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.
    Larrat S; Poveda JD; Coudret C; Fusillier K; Magnat N; Signori-Schmuck A; Thibault V; Morand P
    J Clin Microbiol; 2013 Sep; 51(9):2815-21. PubMed ID: 23616453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
    Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
    J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of IntelliPlex
    Kao JH; Lin CY; Chuang WL; Cheng YY; Hu JY; Liang WK; Friebe P; Palmer S; Huang CS
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):344-348. PubMed ID: 30975461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4.
    Zekri AR; El-Din HM; Bahnassy AA; El-Shehabi AM; El-Leethy H; Omar A; Khaled HM
    J Med Virol; 2005 Mar; 75(3):412-20. PubMed ID: 15648068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis C virus by a user-developed reverse transcriptase-PCR and use of amplification products for subsequent genotyping.
    Tang YW; Li H; Roberto A; Warner D; Yen-Lieberman B
    J Clin Virol; 2004 Oct; 31(2):148-52. PubMed ID: 15364272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis.
    Benedet M; Adachi D; Wong A; Wong S; Pabbaraju K; Tellier R; Tang JW
    J Clin Virol; 2014 Jul; 60(3):301-4. PubMed ID: 24794397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.
    Liu CH; Liang CC; Liu CJ; Lin CL; Su TH; Yang HC; Chen PJ; Chen DS; Kao JH
    J Clin Microbiol; 2015 May; 53(5):1754-7. PubMed ID: 25740780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.
    Yang R; Cong X; Du S; Fei R; Rao H; Wei L
    J Clin Microbiol; 2014 Oct; 52(10):3685-92. PubMed ID: 25100817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid genotyping of hepatitis C virus by primer-specific extension analysis.
    Antonishyn NA; Ast VM; McDonald RR; Chaudhary RK; Lin L; Andonov AP; Horsman GB
    J Clin Microbiol; 2005 Oct; 43(10):5158-63. PubMed ID: 16207978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.
    Ndiaye O; Gozlan J; Diop-Ndiaye H; Sall AS; Chapelain S; LeprĂȘtre A; Maynart M; Gueye M; Lo G; Thiam M; Ba I; Lacombe K; Girard PM; Mboup S; Kane CT
    J Med Virol; 2017 Mar; 89(3):484-488. PubMed ID: 26705258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.